BlackRock
OYST

BlackRock’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

BlackRock’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,085
Closed -$23.3K – 5843
2022
Q4 		$23.3K Sell
2,085
-502,288
-100% -$4.87M ﹤0.01% 5362
2022
Q3 		$2.83M Sell
504,373
-28,911
-5% -$181K ﹤0.01% 4013
2022
Q2 		$2.31M Sell
533,284
-558,550
-51% -$3.18M ﹤0.01% 4195
2022
Q1 		$12.7M Sell
1,091,834
-33,680
-3% -$401K ﹤0.01% 3452
2021
Q4 		$20.6M Buy
1,125,514
+95,344
+9% +$1.21M ﹤0.01% 3258
2021
Q3 		$12.2M Buy
1,030,170
+51,502
+5% +$750K ﹤0.01% 3584
2021
Q2 		$16.8M Buy
978,668
+240,461
+33% +$4.57M ﹤0.01% 3404
2021
Q1 		$13.5M Buy
738,207
+233,797
+46% +$4.9M ﹤0.01% 3408
2020
Q4 		$9.49M Buy
504,410
+14,439
+3% +$311K ﹤0.01% 3389
2020
Q3 		$10.3M Buy
489,971
+67,815
+16% +$1.59M ﹤0.01% 3204
2020
Q2 		$12.2M Buy
422,156
+87,660
+26% +$2.64M ﹤0.01% 3074
2020
Q1 		$11.7M Sell
334,496
-42,061
-11% -$1.36M ﹤0.01% 2916
2019
Q4 		$9.2M Buy
+376,557
New +$6.61M ﹤0.01% 3287

Other funds holding OYST

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BlackRock's OYST Position: Q1 2023 in Review

BlackRock sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 2,085 shares — an estimated $23.3K sold.

BlackRock first reported a position in OYST in Q4 2019 and held it in 13 quarters. The position peaked at $20.6M in Q4 2021. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • BlackRock reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • BlackRock sold 2,085 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $23.3K.
  • BlackRock first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 13 quarters.
  • BlackRock's Oyster Point Pharma, Inc. Common Stock position peaked at $20.6M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on BlackRock's 13F filing for Q1 2023, filed 12 May 2023.